Article

Structural basis for SARS-CoV-2 Nucleocapsid protein recognition by single-domain antibodies

2021-06-01

Abstract excerpt

The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, is the most severe public health event of the twenty-first century. While effective vaccines against SARS-CoV-2 have been developed, there remains an urgent need for diagnostics to quickly and accurately detect infections. Antigen tests, particularly those that detect the abundant SARS-CoV-2 Nucleocapsid protein, are a proven method for detecting active...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9ab42f0f-44e0-574e-ab46-d6a191d85b24
DOI: 10.1101/2021.06.01.446591

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Structural basis for SARS-CoV-2 Nucleocapsid protein recognition by single-domain antibodiesDOI 10.1101/2021.06.01.446591Read

Crystal structures of the SARS‐CoV‐2 nucleocapsid protein C‐terminal domain and development of nucleocapsid‐targeting nanobodiesSemantic proximity Read

Highly Specific Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Antigen for Accurate Diagnosis of COVID-19Semantic proximity Read

Mapping SARS-CoV-2 Nucleocapsid Function with NanobodiesSemantic proximity Read

Affinity tag free purification of SARS-Cov-2 N protein and its crystal structure in complex with ssDNASemantic proximity Read

High-Specificity Targets in SARS-CoV-2 N Protein for Serological Antibody DetectionSemantic proximity Read

A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2Semantic proximity Read

Structures of synthetic nanobody–SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interactionSemantic proximity Read

Mechanism of LLPS of SARS-CoV-2 N proteinSemantic proximity Read

Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2Semantic proximity Read

Structural basis for the participation of the SARS-CoV-2 nucleocapsid protein in the template switch mechanism and genomic RNA reorganizationSemantic proximity Read

Structures of synthetic nanobody–SARS-CoV-2–RBD complexes reveal distinct sites of interaction and recognition of variantsSemantic proximity Read

Use of the Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDsSemantic proximity Read